✦ LIBER ✦

Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure: Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program

✍ Scribed by John E.A. Blair; Faiez Zannad; Marvin A. Konstam; Thomas Cook; Brian Traver; John C. Burnett Jr; Liliana Grinfeld; Holly Krasa; Aldo P. Maggioni; Cesare Orlandi; Karl Swedberg; James E. Udelson; Christopher Zimmer; Mihai Gheorghiade

Book ID: 119267748
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 494 KB
Volume: 52
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2008.07.056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EVEREST (Efficacy of Vasopressin Antagon

EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan)

📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

Causes of death and rehospitalization in

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

✍ Christopher M. O'Connor; Alan B. Miller; John E.A. Blair; Marvin A. Konstam; Pat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Gender Does Not Affect Postdischarge Out

Gender Does Not Affect Postdischarge Outcomes in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan [EVEREST] Trial)

✍ Ami N. Shah; Robert J. Mentz; Mihai Gheorghiade; Mary J. Kwasny; Angela J. Fough 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Effects of tolvaptan on physician-assess

Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials

✍ Peter S. Pang; Mihai Gheorghiade; Jamil Dihu; Karl Swedberg; Sadiya Khan; Aldo P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Rationale and Design of the Multicenter,

Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)

✍ Mihai Gheorghiade; Cesare Orlandi; John C. Burnett Jr.; David DeMets; Liliana Gr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Gender Differences in In-Hospital Manage

Gender Differences in In-Hospital Management and Outcomes in Patients With Decompensated Heart Failure: Analysis From the Acute Decompensated Heart Failure National Registry (ADHERE)

✍ Marie Galvao; Jill Kalman; Teresa Demarco; Gregg C. Fonarow; Catherine Galvin; J 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB